A TWO-YEAR trial of take-home naloxone, involving Australians attempting to reverse opioid overdoses, will be funded by the Federal Government to the value of $7.2 million, 6minutes reports.
The drug will be offered at more places frequented by people at risk of overdosing under the pilot program.
The government is also giving more than $100,000 to the Burnet Institute to work with the National Drug Research Institute on developing a nationally consistent distribution program.
Small-scale programs making the drug available to people at risk of overdosing are already running in several states and territories, with the first launched in the ACT in 2012.
The details of this new trial will be established with the states and territories.
Controversially, the government wants to make the take-home version, which can be injected or used in a nasal spray form, more available through doctors and centres such as drug treatment facilities.
The money will go to primary health networks which commission community health projects.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Mar 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Mar 19
